Next Article in Journal
A Four-Layer Numerical Model for Transdermal Drug Delivery: Parameter Optimization and Experimental Validation Using a Franz Diffusion Cell
Previous Article in Journal
Carbon Dots with Tunable Charge as Mucus-Penetrating Gene Carriers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Therapeutic and Formulation Innovations in the Management of Canine Otitis Externa

1
Centre for Pharmaceutical Innovation (CPI), College of Health Sciences, Adelaide University, Adelaide, SA 5000, Australia
2
Neoculi Pty Ltd., Burwood, VIC 3125, Australia
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceutics 2025, 17(10), 1332; https://doi.org/10.3390/pharmaceutics17101332
Submission received: 1 August 2025 / Revised: 13 September 2025 / Accepted: 10 October 2025 / Published: 14 October 2025

Abstract

Canine Otitis Externa (COE) is a challenging otological disorder in dogs which causes significant irritation and discomfort. This comprehensive review provides an extensive analysis of COE with emphasis on the fundamentals of the condition, starting with the basic anatomy of the canine external ear canal, followed by pathophysiology and diagnosis of COE. Furthermore, novel therapeutic interventions, formulation considerations, and challenges, with the perspective of future directions in the field of COE management, are described. Diagnostic models, including clinical examination, cytology, and susceptibility tests, are presented to provide an overview of the processes involved in detecting and selecting appropriate therapies for the management of COE. Moreover, this paper describes the limitations of current therapies with considerations for the selection of alternative novel treatments such as aromatherapy, acupuncture, bacteriophages, nutraceuticals, and nanomedicines. This review places particular emphasis on the pharmaceutical formulation of topical products used for COE treatment. Various factors, including osmotic pressure, safety profile, viscosity, bioadhesion, and formulation pH, must be considered when developing topical preparations. These parameters are critical in formulation development to enhance therapeutic outcomes and minimise potential side effects. Finally, potential advancements in COE management are highlighted, including the integration of microbial genomics and the significance of managing the microbiota. Overall, this review serves as a valuable resource for those interested in the future of topical treatment of COE by providing a deep understanding of diagnostic, therapeutic, and medical interventions for effective management.
Keywords: canine otitis externa; diagnosis; formulation development canine otitis externa; diagnosis; formulation development
Graphical Abstract

Share and Cite

MDPI and ACS Style

Song, Y.; Kim, S.; Mukhopadhyay, S.; Youssef, S.H.; Tan, J.Q.E.; Weir, E.J.; Page, S.W.; Garg, S. Therapeutic and Formulation Innovations in the Management of Canine Otitis Externa. Pharmaceutics 2025, 17, 1332. https://doi.org/10.3390/pharmaceutics17101332

AMA Style

Song Y, Kim S, Mukhopadhyay S, Youssef SH, Tan JQE, Weir EJ, Page SW, Garg S. Therapeutic and Formulation Innovations in the Management of Canine Otitis Externa. Pharmaceutics. 2025; 17(10):1332. https://doi.org/10.3390/pharmaceutics17101332

Chicago/Turabian Style

Song, Yunmei, Sangseo Kim, Songhita Mukhopadhyay, Souha H. Youssef, Jin Quan Eugene Tan, Emily Josephine Weir, Stephen W. Page, and Sanjay Garg. 2025. "Therapeutic and Formulation Innovations in the Management of Canine Otitis Externa" Pharmaceutics 17, no. 10: 1332. https://doi.org/10.3390/pharmaceutics17101332

APA Style

Song, Y., Kim, S., Mukhopadhyay, S., Youssef, S. H., Tan, J. Q. E., Weir, E. J., Page, S. W., & Garg, S. (2025). Therapeutic and Formulation Innovations in the Management of Canine Otitis Externa. Pharmaceutics, 17(10), 1332. https://doi.org/10.3390/pharmaceutics17101332

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop